Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.3617
-0.0208 (-5.44%)
At close: Nov 3, 2025, 4:00 PM EST
0.3527
-0.0090 (-2.49%)
After-hours: Nov 3, 2025, 5:21 PM EST
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $17.91 million as of November 3, 2025. Its market cap has decreased by -82.48% in one year.
Market Cap
17.91M
Enterprise Value
26.02M
1-Year Change
-82.48%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $17.91M, a decrease of -94.88%. That is a compound annual growth rate of -56.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 18.94M | -78.79% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |